RESUMEN
In the present study, we examined the effects of free fatty acids (FFAs) on insulin sensitivity and signaling cascades in the C2C12 skeletal muscle cell culture system. Our data clearly manifested that the inhibitory effects of PKC on insulin signaling may at least in part be explained by the serine/threonine phosphorylation of IRS-1. Both oleate and palmitate treatment were able to increase the Serine(307) phosphorylation of IRS-1. IRS-1 Serine(307) phosphorylation is inducible which causes the inhibition of IRS-1 tyrosine phosphorylation by either IkappaB-kinase (IKK) or c-jun N-terminal kinase (JNK) as seen in our proteomic kinases screen. Furthermore, our proteomic data have also manifested that the two FFAs activate the IKKalpha/beta, the stress kinases S6 kinase p70 (p70SK), stress-activated protein kinase (SAPK), JNK, as well as p38 MAP kinase (p38MAPK). On the other hand, the antioxidant, Taurine at 10mM concentrations was capable of reversing the oleate-induced insulin resistance in myocytes as manifested from the glucose uptake data. Our current data point out the importance of FFA-induced insulin resistance via multiple signaling mechanisms.
Asunto(s)
Ácidos Grasos no Esterificados/metabolismo , Glucosa/metabolismo , Resistencia a la Insulina , Insulina/metabolismo , Mioblastos Esqueléticos/metabolismo , Proteína Quinasa C/metabolismo , Animales , Antioxidantes/farmacología , Línea Celular , Activación Enzimática , Ácidos Grasos no Esterificados/farmacología , Insulina/farmacología , Proteínas Sustrato del Receptor de Insulina/metabolismo , Ratones , Mioblastos Esqueléticos/efectos de los fármacos , Ácido Oléico/metabolismo , Ácido Oléico/farmacología , Estrés Oxidativo , Ácido Palmítico/metabolismo , Ácido Palmítico/farmacología , Fosforilación , Serina/metabolismo , Transducción de Señal , Taurina/farmacologíaRESUMEN
In the current study, we show evidence, in a fructose-fed hamster model of insulin resistance, that free fatty acid (FFA) can induce hepatic insulin resistance in part via PKC activation leading to increased production of atherogenic apoB100-containing lipoproteins. Interestingly, IkappaB-kinase beta (IKKbeta)-dependent NF-kappaB was activated in hepatocytes from the fructose-fed hamster as an indication for PKC activation. Treatment of hepatocytes with oleate for 16h showed the activation of the PKC isoforms, PKCalpha/betaII, in a dose dependent manner. Strikingly, the general PKC inhibitor, bisindolylmaleimide-I, Bis-I (5 microM) was found to ameliorate fructose-induced insulin resistance, restoring the phosphorylation status of PKB and suppressing apoB100 overproduction in ex vivo and in vivo. The data suggest that hepatic PKC activation, induced by increased circulating FFA may be an important factor in the development of insulin resistance and dyslipidemia seen in the fructose-fed hamster model.
Asunto(s)
Apolipoproteína B-100/metabolismo , Ácidos Grasos no Esterificados/metabolismo , Hiperlipoproteinemias/etiología , Resistencia a la Insulina , Hígado/metabolismo , FN-kappa B/metabolismo , Proteína Quinasa C/metabolismo , Animales , Cricetinae , Modelos Animales de Enfermedad , Fructosa/administración & dosificación , Hepatocitos/efectos de los fármacos , Hepatocitos/metabolismo , Hiperlipoproteinemias/metabolismo , Indoles/farmacología , Hígado/citología , Hígado/efectos de los fármacos , Masculino , Maleimidas/farmacología , Mesocricetus , Ácido Oléico/farmacología , Fosforilación , Proteína Quinasa C/antagonistas & inhibidores , Inhibidores de Proteínas Quinasas/farmacologíaRESUMEN
2-Aminopurine (2-AP) is an adenine analog shown to cause cells to bypass chemical- and radiation-induced cell cycle arrest through as-yet unidentified mechanisms. 2-AP has also been shown to act as a kinase inhibitor. Tumor suppressor p53 plays an important role in the control of cell cycle and apoptosis in response to genotoxic stress. We were interested in examining the effect of 2-AP on p53 phosphorylation and its possible consequences on checkpoint control in cells subjected to various forms of DNA damage. Here, we show that 2-AP suppresses p53 phosphorylation in response to gamma radiation, adriamycin, or ultraviolet treatment. This is partly explained by the ability of the kinase inhibitor to inhibit ATM or ATR activities in vitro and impair ATM- or ATR-dependent p53 phosphorylation in vivo. However, 2-AP is also capable of inhibiting p53 phosphorylation in cells deficient in ATM, DNA-PK, or ATR suggesting the existence of multiple pathways by which this kinase inhibitor modulates p53 activation. Biologically, the 2-AP-mediated inhibition of p53 stabilization enables wild-type p53-containing cells to bypass adriamycin-induced G(2)/M arrest. In the long term, however, 2-AP facilitates cells to resist DNA damage-induced cell death independently of p53.